Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
5a-Reductase inhibitors and risk of high-grade or lethal prostate cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
5a-Reductase inhibitors and risk of high-grade or lethal prostate cancer.
5a-Reductase inhibitors and risk of high-grade or lethal prostate cancer. JAMA Intern Med. 2014 Aug; 174(8):1301-7.
View in:
PubMed
subject areas
5-alpha Reductase Inhibitors
Adult
Aged
Cohort Studies
Disease Progression
Humans
Incidence
Longitudinal Studies
Male
Middle Aged
Proportional Hazards Models
Prospective Studies
Prostatic Hyperplasia
Prostatic Neoplasms
Risk Factors
authors with profiles
Aria F. Olumi, M.D.
Massimo Loda, M.D.
Meir Jonathan Stampfer, Dr.P.H., M.D.
Mark A Preston, M.D.
Edward L. Giovannucci, D.Sc., M.D.
Lorelei Ann Mucci, Sc.D.
Sarah Coseo Markt